Michael Platten

Affiliations: 
Hertie-Institute for Clinical Brain Research Eberhard Karls Universität Tübingen, Tübingen, Baden-Württemberg, Germany 
Google:
"Michael Platten"
Cross-listing: Neurotree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hunger J, Schregel K, Boztepe B, et al. (2023) nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma. Theranostics. 13: 5170-5182
Grassl N, Poschke I, Lindner K, et al. (2023) A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nature Medicine. 29: 2586-2592
Schregel K, Heinz L, Hunger J, et al. (2023) A cellular ground truth to develop MRI signatures in glioma models by correlative light sheet microscopy and atlas-based co-registration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Turco V, Pfleiderer K, Hunger J, et al. (2023) T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles. Nature Communications. 14: 771
Miller JJ, Gonzalez Castro LN, McBrayer S, et al. (2022) Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology
Reinhardt A, Pfister K, Schrimpf D, et al. (2022) Anaplastic ganglioglioma - a diagnosis comprising several distinct tumour types. Neuropathology and Applied Neurobiology. e12847
Kilian M, Friedrich M, Sanghvi K, et al. (2021) T cell receptor therapy targeting mutant capicua transcriptional repressor in experimental gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Blobner J, Kilian M, Tan CL, et al. (2021) Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neuro-Oncology Advances. 3: vdab147
Platten M, Bunse L, Wick A, et al. (2021) A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature
Koelsche C, Schrimpf D, Stichel D, et al. (2021) Sarcoma classification by DNA methylation profiling. Nature Communications. 12: 498
See more...